Cantor Fitzgerald
Cantor Fitzgerald is a leading brokerage service for Wall Street's fixed income inter-dealer community. Cantor is a recognized leader in the specialized areas of equity and fixed income capital markets, offering an impressive array of products and services to more than 5000 institutional clients around the world.
Cantor suffered a devastating loss on September 11, 2001, when the World Trade Center terrorist attacks claimed the lives of 658 of the company's 960 New York-based employees.
Howard W. Lutnick is the company's Chairman and CEO.
View Older Stories View More Recent Stories
-
Cantor Fitzgerald Defends Corbus Pharmaceuticals (CRBP) Following Short Report
-
Cantor Fitzgerald Upgrades EastGroup Properties (EGP) to Hold
-
Abeona Therapeutics (ABEO) ABO-102 Data is a 'Promising Start' - Cantor Fitzgerald
-
A.M. Best to Host Webinar on What Insurers Should Know about ETFs & Issuers
-
Notable Analyst Rating Changes 10/19: (TWTR) (YUM) (WNR) Upgraded; (FE) (Q) (NCLH) Lower
-
Cantor Fitzgerald Starts GoDaddy Inc (GDDY) at Buy
-
Cantor Fitzgerald Starts Wix.com (WIX) at Buy
-
Cantor Fitzgerald Starts Endurance International Group (EIGI) at Hold
-
Cantor Fitzgerald Starts Web.com, Inc. (WEB) at Hold
-
ELS Reports Third Quarter Results
-
Omeros (OMER): Reiterating $21 PT On Solid Prelim Phase II Data - Cantor Fitzgerald
-
PlacementTracker Publishes Q3 2016 Private Placement Market League Tables
-
Unusual 11 Mid-Day Movers 10/14: (CTRV) (FBMS) (MGT) Higher; (OPTT) (TAYD) (BIOC) Lower
-
Notable Analyst Rating Changes 10/14: (UA) (CAG) (LVLT) Upgraded; (URI) (BLUE) (RDS-A) Downgraded
-
UPDATE: Cantor Fitzgerald Downgrades bluebird bio (BLUE) to Sell
-
First Empire Adds Asset-Backed Securities Trader and Expands Product Lineup
-
Cantor Fitzgerald Downgrades Flex Pharma (FLKS) to Hold
-
Cidara Therapeutics Announces Closing of Public Offering of Common Stock, Including Exercise of Underwriter’s Option to Purchase Additional Shares
-
Orchid Island Capital Announces October 2016 Monthly Dividend and September 30, 2016 RMBS Portfolio Characteristics
-
Amazon's (AMZN) Price Target Raised to $1000 at Cantor Fitzgerald
-
Cantor Fitzgerald Downgrades Chatham Lodging Trust (CLDT) to Hold
-
Cidara Therapeutics (CDTX) Prices 2.48M Common Stock Offering at $10.10/Share
-
Cidara Therapeutics Announces Pricing of Public Offering of Common Stock
-
Cantor Fitzgerald Starts Fiserv (FISV) at Hold
-
Cantor Fitzgerald Starts Fidelity National Information Services (FIS) at Buy
-
Cidara Therapeutics (CDTX) to Offer Common Stock
-
Cidara Therapeutics Announces Commencement of Public Offering of Common Stock
-
Cantor Fitzgerald Starts The Trade Desk (TTD) at Buy
-
Notable 52-Week Highs and Lows 10/5: (ECA) (REN) (CRBP) High; (TEVA) (TTD) Low
-
Unusual 11 Mid-Day Movers 10/5: (CPRX) (CRBP) (UEPS) Higher; (IMMU) (AZZ) (CTSO) Lower
-
Notable Analyst Rating Changes 10/5: (JONE) (PAA) (CMRE) Upgraded; (NCLH) (GNW) (VNR) Downgraded
-
Pre-Open Stock Movers 10/05: (CPRX) (ACIA) (TWTR) Higher; (IMMU) (ULH) (CRM) Lower (more...)
-
After-Hours Stock Movers 10/04: (ACIA) (CRBP) (TMH) Higher; (ULH) (CASC) (MU) Lower (more...)
-
Cantor Fitzgerald Starts Amarin Corporation (AMRN) at Buy
-
Cantor Fitzgerald Starts Corbus Pharmaceuticals (CRBP) at Buy
-
Cantor Fitzgerald affiliate pays $22.5 million to end U.S. gambling probe
-
Fitch Reviews Inter-Dealer Brokers
-
Fitch Affirms BGC at 'BBB-'; Outlook Stable
-
Fitch Affirms Cantor Fitzgerald at 'BBB-'; Outlook Stable
-
Cantor Fitzgerald Starts CardConnect Corp. (CCN) at Buy
-
Cantor Fitzgerald Says Arrowhead Pharma's (ARWR) RNAi Deal with Amgen Validates Platform; Affirms at 'Buy'
-
Cantor Fitzgerald Downgrades Alcobra Ltd. (ADHD) to Hold
-
Galmed Pharma (GLMD) Updates on 'At-The-Market' Financing Program; Says ~$5M Raised
-
Galmed Pharmaceuticals Announces that it has Raised Approximately $5.0 Million to Date Under its ATM Program
-
Form 4 BGC Partners, Inc. For: Sep 23 Filed by: CANTOR FITZGERALD, L. P.
-
Generator Announces North American Expansion Plans, Appoints Vice President of Development
-
Yelp (YELP) Gains as Analyst Says Share Conversion Makes Takeover 'Easier', 'More Likely'
-
GW Pharma (GWPH) PT Raised to $182 at Cantor Fitzgerald Following Successful Second LGS Trial
-
Reminder -- Capital Link's 3rd Annual Dissect ETFs Forum Thursday, September 29, 2016 -- the Metropolitan Club, New York City
-
Glaukos Corporation (GKOS): Durable Efficacy Data in iStent Study - Cantor

